HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Viscum ribosome inactivating protein

type 2 RIP of 264 aa, MW 60 kDa; viscotoxin is also available; ML1 binds B-galactosides, ML2 binds B-gal & NAG, ML3 binds N-acetyl-galactosides; aviscumine produced in E. coli via recombinant DNA
Also Known As:
ribosome inactivating protein, Viscum; aviscumine
Networked: 8 relevant articles (0 outcomes, 6 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Witthohn, Klaus: 4 articles (01/2014 - 09/2005)
2. Schöffski, P: 3 articles (02/2015 - 12/2004)
3. Lentzen, Hans: 3 articles (01/2014 - 08/2008)
4. Wilhelm-Ogunbiyi, Karin: 3 articles (08/2008 - 09/2005)
5. Fumoleau, P: 2 articles (02/2015 - 12/2004)
6. Schöffski, Patrick: 2 articles (07/2011 - 10/2005)
7. Bergmann, Lothar: 2 articles (07/2011 - 08/2008)
8. Zwierzina, Heinz: 2 articles (07/2011 - 08/2008)
9. Langer, Martin: 2 articles (10/2005 - 09/2005)
10. Wilhelm-Ogunbiyi, K: 2 articles (07/2005 - 12/2004)

Related Diseases

1. Neoplasms (Cancer)
2. Melanoma (Melanoma, Malignant)
3. Glioma (Gliomas)
4. Carcinoma (Carcinomatosis)
5. Adenocarcinoma

Related Drugs and Biologics

1. mistletoe lectin I
2. Doxorubicin (Adriamycin)
3. Cyclophosphamide (Cytoxan)
4. erlotinib (CP 358,774)

Related Therapies and Procedures

1. Radiotherapy
2. Drug Therapy (Chemotherapy)